Business Description
Pliant Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US7291391057
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.25 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.33 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -76 | |||||
3-Year EBITDA Growth Rate | -12.6 | |||||
3-Year EPS without NRI Growth Rate | -12.1 | |||||
3-Year FCF Growth Rate | -3.2 | |||||
3-Year Book Growth Rate | -0.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | -15.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 92 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.45 | |||||
9-Day RSI | 38.57 | |||||
14-Day RSI | 43.54 | |||||
6-1 Month Momentum % | -20.86 | |||||
12-1 Month Momentum % | -26.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.47 | |||||
Quick Ratio | 14.47 | |||||
Cash Ratio | 14.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19 | |||||
Shareholder Yield % | -3.03 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -8942.03 | |||||
ROE % | -39.62 | |||||
ROA % | -35.21 | |||||
ROIC % | -805.51 | |||||
3-Year ROIIC % | -2662.56 | |||||
ROC (Joel Greenblatt) % | -1103.5 | |||||
ROCE % | -36.9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 453.7 | |||||
PB Ratio | 1.88 | |||||
Price-to-Tangible-Book | 1.83 | |||||
EV-to-EBIT | -2.01 | |||||
EV-to-Forward-EBIT | -0.55 | |||||
EV-to-EBITDA | -2.03 | |||||
EV-to-Revenue | 233.19 | |||||
EV-to-Forward-Revenue | 36.84 | |||||
EV-to-FCF | -2.64 | |||||
Price-to-Net-Current-Asset-Value | 2.02 | |||||
Price-to-Net-Cash | 2.08 | |||||
Earnings Yield (Greenblatt) % | -49.75 | |||||
FCF Yield % | -18.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pliant Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.449 | ||
EPS (TTM) (€) | -2.862 | ||
Beta | 1.7 | ||
Volatility % | 60.5 | ||
14-Day RSI | 43.54 | ||
14-Day ATR (€) | 0.375924 | ||
20-Day SMA (€) | 11.485 | ||
12-1 Month Momentum % | -26.67 | ||
52-Week Range (€) | 9.55 - 17.4 | ||
Shares Outstanding (Mil) | 60.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pliant Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pliant Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pliant Therapeutics Inc Frequently Asked Questions
What is Pliant Therapeutics Inc(STU:9PT)'s stock price today?
When is next earnings date of Pliant Therapeutics Inc(STU:9PT)?
Does Pliant Therapeutics Inc(STU:9PT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |